Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis [2]

Clinical Rheumatology

Volumn 25, Issue 4, 2006, Pages 610-611

  Matsui, Toshihiro ^a   Shimada, Kota ^b   Tohma, Shigeto ^b  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Anti cyclic citrullinated peptide antibody; Rheumatic disease; Rheumatoid arthritis

Indexed keywords

BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; STROMELYSIN;

ARTHRALGIA; BLOOD SAMPLING; CORRELATION ANALYSIS; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; INCIDENCE; JOINT DESTRUCTION; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; REFERENCE VALUE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; HUMANS; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; RHEUMATIC DISEASES;

EID: 33746503066     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0108-y     Document Type: Letter

References (9)

1. Yamada R, Suzuki A, Chang X, Yamamoto K (2005) Citrullinated proteins in rheumatoid arthritis. Front Biosci 10:54-64
2. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A et al (2003) Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120-126
3. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B, BARFOT Study Group (2004) Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: Role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 63:1090-1095
4. Suzuki K, Sawada T, Murakami A, Matsui T, Tohma S, Nakazono K, Takemura M, Takasaki Y, Mimori T, Yamamoto K (2003) High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32:197-204
5. Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J et al (2005) Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome. Ann Rheum Dis 64:114-117
6. Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N (2005) The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxf) 44:1056-1060
7. van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B et al (2003) Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol 30:825-828
8. Kasapcopur O, Altun S, Aslan M, Karaarslan S, Kamburoglu-Goksel A, Saribas S et al (2004) Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 63:1687-1689
9. Vossenaar ER, Smeets TJ, Kraan MC, Raars JM, van Venrooij WJ, Tak PP (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50:3485-3494